Free Trial

TerrAscend Corp. (OTCMKTS:TSNDF) Sees Large Drop in Short Interest

TerrAscend logo with Medical background

TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 1,956,500 shares, a decrease of 12.3% from the April 30th total of 2,230,400 shares. Currently, 1.0% of the company's stock are short sold. Based on an average trading volume of 1,480,900 shares, the days-to-cover ratio is presently 1.3 days.

Analyst Upgrades and Downgrades

Separately, Atb Cap Markets raised shares of TerrAscend from a "hold" rating to a "strong-buy" rating in a research report on Thursday, May 8th.

Read Our Latest Research Report on TSNDF

TerrAscend Stock Performance

Shares of TSNDF traded down $0.00 during midday trading on Thursday, reaching $0.30. 330,674 shares of the stock were exchanged, compared to its average volume of 634,420. The company has a market capitalization of $88.68 million, a price-to-earnings ratio of -1.10 and a beta of 1.43. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.35 and a quick ratio of 0.69. TerrAscend has a twelve month low of $0.23 and a twelve month high of $1.75. The business's 50-day moving average price is $0.35 and its 200 day moving average price is $0.52.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02). The firm had revenue of $71.00 million during the quarter, compared to analysts' expectations of $71.63 million. TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%. On average, sell-side analysts expect that TerrAscend will post -0.14 EPS for the current fiscal year.

About TerrAscend

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.

See Also

Should You Invest $1,000 in TerrAscend Right Now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines